JP2022526446A - 皮膚の健康を改善するための、ならびに病原微生物に関連する疾患、障害、及び病態の治療及び予防のための、組成物及び方法 - Google Patents

皮膚の健康を改善するための、ならびに病原微生物に関連する疾患、障害、及び病態の治療及び予防のための、組成物及び方法 Download PDF

Info

Publication number
JP2022526446A
JP2022526446A JP2021560596A JP2021560596A JP2022526446A JP 2022526446 A JP2022526446 A JP 2022526446A JP 2021560596 A JP2021560596 A JP 2021560596A JP 2021560596 A JP2021560596 A JP 2021560596A JP 2022526446 A JP2022526446 A JP 2022526446A
Authority
JP
Japan
Prior art keywords
janthinobacterium
composition
seq
human
liverium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021560596A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022526446A5 (https=
Inventor
ロバート エム． ブルッカー
シューチェン チャン
イダ リスター
サンジャイ ジャイン
Original Assignee
ダームビオント インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ダームビオント インコーポレイテッド filed Critical ダームビオント インコーポレイテッド
Publication of JP2022526446A publication Critical patent/JP2022526446A/ja
Publication of JP2022526446A5 publication Critical patent/JP2022526446A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
JP2021560596A 2019-04-09 2020-04-09 皮膚の健康を改善するための、ならびに病原微生物に関連する疾患、障害、及び病態の治療及び予防のための、組成物及び方法 Pending JP2022526446A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962920010P 2019-04-09 2019-04-09
US62/920,010 2019-04-09
PCT/US2020/027556 WO2020210553A1 (en) 2019-04-09 2020-04-09 Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes

Publications (2)

Publication Number Publication Date
JP2022526446A true JP2022526446A (ja) 2022-05-24
JP2022526446A5 JP2022526446A5 (https=) 2023-04-18

Family

ID=70476522

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021560596A Pending JP2022526446A (ja) 2019-04-09 2020-04-09 皮膚の健康を改善するための、ならびに病原微生物に関連する疾患、障害、及び病態の治療及び予防のための、組成物及び方法

Country Status (12)

Country Link
US (5) US20220160617A1 (https=)
EP (1) EP3952848A1 (https=)
JP (1) JP2022526446A (https=)
KR (1) KR20220003539A (https=)
CN (1) CN113853198A (https=)
AU (1) AU2020271885A1 (https=)
BR (1) BR112021020247A2 (https=)
CA (1) CA3132858A1 (https=)
IL (1) IL287032A (https=)
MX (1) MX2021012391A (https=)
SG (1) SG11202111168UA (https=)
WO (1) WO2020210553A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12491220B2 (en) 2024-02-23 2025-12-09 Imvela Corp. Compositions containing indole-derived metabolites and methods of use thereof

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2658897T3 (es) 2011-08-24 2018-03-12 Novan, Inc. Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
SG11202111168UA (en) * 2019-04-09 2021-11-29 Dermbiont Inc Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
US11517597B2 (en) * 2020-09-29 2022-12-06 Chambio Co., Ltd. Method for improving skin condition with postbiotic extract
CN112891343B (zh) * 2021-03-22 2022-04-01 华中农业大学 3-吲哚乙腈在制备抑制新型冠状病毒SARS-CoV-2药物中的应用
TWI890918B (zh) * 2022-01-24 2025-07-21 耀然實業股份有限公司 私密處保養組成物、私密處保養產品及私密處用品
CN114705800A (zh) * 2022-03-25 2022-07-05 重庆市公共卫生医疗救治中心 尿液中生物标志物检测试剂在制备新冠肺炎病毒无症状感染者筛查试剂盒中的用途
AU2023271525A1 (en) * 2022-05-16 2024-12-05 Maruho Co., Ltd. Composition for treating ringworm
US20260021219A1 (en) * 2022-09-30 2026-01-22 Kimberly-Clark Worldwide, Inc. Methods and absorbent articles for inhibiting fecal protease activity
EP4438052A1 (en) * 2023-03-30 2024-10-02 FytagoLife B.V. Plant extract for use in treatment of a fungal infection
KR20260049280A (ko) * 2023-08-07 2026-04-13 로레알 피부 항-노화 치료를 위한 새로운 조성물
KR20250104680A (ko) * 2023-12-29 2025-07-08 한국생명공학연구원 잔티노박테리움 속 균주 또는 비올라세인을 포함하는 발모 촉진 또는 탈모 예방 또는 치료용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011003062A2 (en) * 2009-07-03 2011-01-06 James Madison University Probiotic compositions and processes thereof

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3261761A (en) 1962-05-07 1966-07-19 Arthur W Anderson Method of freeze drying bacterial cultures
US4205132A (en) 1978-07-17 1980-05-27 Microlife Technics, Inc. Lyophilization of bacteria
EP0045718A3 (de) 1980-07-25 1983-01-19 Ciba-Geigy Ag Nasalpräparate und Verfahren zu deren Herstellung
US4900348A (en) 1983-08-02 1990-02-13 The Ohio State University Research Foundation Production of disease suppresive compost and container media, and microorganism culture for use therein
US5081225A (en) 1989-02-09 1992-01-14 E. R. Squibb & Sons, Inc. Gram-positive and gram-negative antibacterial compounds from the microorganism, janthinobacterium lividum
JPH05194141A (ja) 1992-01-14 1993-08-03 Mitsubishi Kasei Corp 化粧料
JPH06247964A (ja) 1993-02-22 1994-09-06 Snow Brand Milk Prod Co Ltd 新規生理活性物質ｈｓ−１及びその製造方法
IT1296148B1 (it) 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
US5888396A (en) 1996-12-17 1999-03-30 Perriello; Felix Anthony Bioremediation of pollutants with butane-utilizing bacteria
US6244346B1 (en) 1996-12-17 2001-06-12 Global Biosciences, Inc. Method and apparatus for reducing fouling of injection and recovery wells
US6716435B1 (en) 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6645506B1 (en) 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ATE493139T1 (de) 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US7507402B1 (en) 1997-04-18 2009-03-24 Ganeden Biotech, Inc. Topical use of probiotic Bacillus spores to prevent or control microbial infections
US7374753B1 (en) 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
US6811786B1 (en) 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US6224863B1 (en) 1998-10-30 2001-05-01 University Of South Carolina Antibiotic composition from alcaligenes species and method for making and using the same
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
EP1212093B1 (en) 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
JP4554745B2 (ja) 1999-11-18 2010-09-29 日本合成化学工業株式会社 乳化重合用分散剤およびその用途
JP2001269699A (ja) 2000-03-24 2001-10-02 Japan Science & Technology Corp 硝酸汚染地下水の直接浄化方法
US20030072829A1 (en) 2001-01-05 2003-04-17 Austin Richard M. Bacterial isolates from organisms that respire at least partially through their skin and biologically active extracts derived therefrom
AUPS057102A0 (en) 2002-02-15 2002-03-07 Vri Biomedical Ltd Compositions and methods for treatment of skin disorders
WO2003074660A2 (en) 2002-02-28 2003-09-12 New England Biolabs, Inc. Modified chitin binding domain and uses thereof
US20040243076A1 (en) 2003-05-13 2004-12-02 Sca Hygiene Products Ab Hygiene product with a probiotic composition
US7244607B2 (en) 2003-10-01 2007-07-17 The United States Of America, As Represented By The Secretary Of Agriculture Chromobacterium subtsugae sp. nov. for control of insect pests
JP2005126375A (ja) 2003-10-24 2005-05-19 Shimomura Kinue 乳酸飲料水
MXPA06015184A (es) 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
JP2006253864A (ja) 2005-03-09 2006-09-21 Fujitsu Ltd データ蓄積型転送方法及びそのシステム並びに装置
US7385203B2 (en) 2005-06-07 2008-06-10 Hitachi, Ltd. Charged particle beam extraction system and method
KR100802494B1 (ko) 2006-02-24 2008-02-12 (주)한국바이오케미칼 비올라세인을 함유하는 해충 방제제, 항진균제 및 그의제조방법
JP2007227290A (ja) 2006-02-27 2007-09-06 Canon Inc 画像表示装置および映像受信表示装置
CN101659698B (zh) * 2008-08-26 2012-03-28 清华大学 紫色杆菌素合成相关蛋白质系统及其编码基因簇与应用
CN101386834A (zh) * 2008-10-28 2009-03-18 清华大学 生产紫色杆菌素的方法及重组菌
JP2010113169A (ja) 2008-11-07 2010-05-20 Kagawa Univ 凸版印刷用版材及びその製造方法
JP2011152687A (ja) 2010-01-27 2011-08-11 Seiko Epson Corp 液体吐出装置の調整方法及び補正値の算出方法
WO2012098358A1 (en) 2011-01-20 2012-07-26 Biopharma Technology Ltd Freeze drying method
KR101982491B1 (ko) 2011-08-30 2019-05-27 아카데미쉬 메디쉬 센트륨 인슐린 저항 예방 및/또는 치료 방법
HUE029357T2 (en) 2012-05-08 2017-02-28 Adaptive Biotechnologies Corp Preparations and devices for measuring and calibrating amplification distortion in multiplex PCR reactions
WO2014029578A1 (en) 2012-08-24 2014-02-27 Haldor Topsøe A/S Method and catalyzed filter element with improved alkali-resistance for flue gas cleaning
WO2014145958A2 (en) 2013-03-15 2014-09-18 Seres Health, Inc. Network-based microbial compositions and methods
CN105979952B (zh) 2013-11-25 2022-04-08 赛里斯治疗公司 协同细菌组合物以及其制造方法和用途
EP4299122A3 (en) 2014-05-07 2024-03-27 The Regents of The University of California Compositions and methods for treating skin and mucous membrane diseases
CN104293703A (zh) * 2014-09-22 2015-01-21 中国农业科学院农产品加工研究所 一种高产紫色杆菌素的兰黑紫色杆菌及其应用
WO2019118984A2 (en) * 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
UA126440C2 (uk) 2018-12-27 2022-10-05 Ігор Семенович Марков Полівалентна комбінована інактивована рідка вакцина проти збудників бактеріальних і грибкових захворювань сечостатевої системи, спосіб її виготовлення і спосіб лікування та профілактики нею
WO2020179999A1 (ko) 2019-03-07 2020-09-10 씨제이제일제당(주) 바실러스 서브틸리스 cjbs303 및 이를 포함하는 조성물
SG11202111168UA (en) * 2019-04-09 2021-11-29 Dermbiont Inc Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011003062A2 (en) * 2009-07-03 2011-01-06 James Madison University Probiotic compositions and processes thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Janthinobacterium sp. HC5-1 16S ribosomal RNA gene, partial sequence", GENBANK: JF313003.1, JPN6025025720, 10 March 2012 (2012-03-10), ISSN: 0005624877 *
BRUCKER RM，: "Amphibian chemical defense: antifungal metabolites of the microsymbi Y STN ont Janthinobacterium liv", J CHEM ECOL, vol. 34巻11号, JPN6024011210, 2008, pages 1422 - 1429, ISSN: 0005412346 *
DERMBIONT, BEGINS PHASE 2 CLINICAL TRIAL FOR ATHLETE'S FOOT WITH A LIVE BACTERIAL TOPICAL PROBIOTIC, vol. [検索日2024.02.19], JPN6024011209, 13 March 2019 (2019-03-13), ISSN: 0005624873 *
JANTHINOBACTERIUM SP. 1_2014MBL_MICDIV, COMPLETE GENOME, JPN6024011212, 2016, ISSN: 0005624875 *
RAMSEY JP: "The cutaneous bacterium Janthinobacterium lividum inhibits the growth Y STN of Trichophyton rubrum i", INT J DERMATOL, vol. 54巻2号, JPN6024011211, 2015, pages 156 - 159, ISSN: 0005624874 *
渡邊日佳流: "ヒト細菌叢の個人特異性と常在因子の解明", 東京工業大学 生命理工学院 生命理工学系 生命理工学コース 博士論文, JPN6024011213, March 2019 (2019-03-01), pages 1 - 148, ISSN: 0005412347 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12491220B2 (en) 2024-02-23 2025-12-09 Imvela Corp. Compositions containing indole-derived metabolites and methods of use thereof

Also Published As

Publication number Publication date
US20220160617A1 (en) 2022-05-26
WO2020210553A1 (en) 2020-10-15
US12064459B2 (en) 2024-08-20
CA3132858A1 (en) 2020-10-15
SG11202111168UA (en) 2021-11-29
EP3952848A1 (en) 2022-02-16
AU2020271885A1 (en) 2021-11-25
IL287032A (en) 2021-12-01
US11040077B2 (en) 2021-06-22
KR20220003539A (ko) 2022-01-10
US20210386802A1 (en) 2021-12-16
US20200345799A1 (en) 2020-11-05
CN113853198A (zh) 2021-12-28
MX2021012391A (es) 2022-01-18
US20210361725A1 (en) 2021-11-25
US20250295713A1 (en) 2025-09-25
BR112021020247A2 (pt) 2021-12-21

Similar Documents

Publication Publication Date Title
JP2022526446A (ja) 皮膚の健康を改善するための、ならびに病原微生物に関連する疾患、障害、及び病態の治療及び予防のための、組成物及び方法
US20240269198A1 (en) Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with fungi and other pathogenic microbes
US20240100105A1 (en) Bacteriophage treatment for acne and biofilms
ES2985966T3 (es) Preparados dermatológicos para mantener y/o restaurar la microbiota saludable de la piel
US12303538B2 (en) High potency stable formulations of vaginal lactobacillus
AU2019339515B2 (en) Bacteriotherapy against proprionibacterium acnes for the treatment of acne
JP2021523900A (ja) 皮膚疾病の処置のための組成物
JP2024164175A (ja) Ｃｈｒｉｓｔｅｎｓｅｎｅｌｌａ ｍｉｎｕｔａを含むＣｈｒｉｓｔｅｎｓｅｎｅｌｌａｃｅａｅ細菌およびその使用
US20190308031A1 (en) Skin disorder therapeutics and methods of use
US11752178B2 (en) Methods for the isolation of microbes with enhanced persistance and compositions with such microbes
Xu et al. Vaginal colonization of Lactobacilli: Mechanism and function
JP2021532099A (ja) アトピー性皮膚炎を処置するためのグラム陰性種の使用
HK40066550A (zh) 用於改善皮肤健康和用於治疗和预防与病原微生物相关联的疾病、疾患和病症的组合物和方法
HK40099263A (zh) 用於改善皮肤健康以及用於治疗和预防与真菌及其他病原微生物相关的疾病、病症和病况的组合物和方法
CN103649306A (zh) 在d乳酸生产中有缺陷以及具有改善的免疫特征的约氏乳杆菌菌株cncm i-1225的天然衍生物
WO2026057073A1 (zh) 一种梭菌属细菌及其应用
WO2021127494A2 (en) Methods and compositions comprising a bacteria with increased viability and faster revivability
AU2021353115A9 (en) Therapeutic bacterial composition
MX2014012904A (es) Carboxamidas y sus sales farmaceuticamente aceptables para usarse en el tratamiento de dermatosis sensibles a esteroides.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211221

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230410

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230410

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20231205

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240325

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240625

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240910

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241203

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20250310

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250624